1. 2022
  2. Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study

    de la Court, J. R., Woudt, S. H. S., Schoffelen, A. F., Heijmans, J., de Jonge, N. A., van der Bruggen, T., Bomers, M. K., Lambregts, M. M. C., Schade, R. P., Sigaloff, K. C. E., ISIS-AR study group, Stuart, J. W. T. C., Melles, D. C., van Dijk, K., Alzubaidy, A., Werdmuller, B. F. M., Blaauw, G. J., Diederen, B. M. W., Alblas, H. J., der Kuil, W. A., & 51 othersBierman, S. M., de Greeff, S. C., Groenendijk, S. R., Hertroys, R., Kuijper, E. J., Monen, J. C., Notermans, D. W., van den Reek, W. J., Smilde, A. E., Wielders, C. C. H., Zoetigheid, R. E., van den Bijllaardt, W., Kraan, E. M., Mattsson, E. E., da Silva, J. M., de Jong, E., Maraha, B., van Asselt, G. J., Demeulemeester, A., Wintermans, B. B., van Trijp, M., Ott, A., Sinnige, J., Melles, D. C., Silvis, W., Bakker, L. J., Dorigo-Zetsma, J. W., Waar, K., Bernards, A. T., Hall, M. A. L., Schaftenaar, E., Nabuurs-Franssen, M. H., Wertheim, H., Diederen, B. M. W., Bode, L., van Rijn, M., Dinant, S., Pontesilli, O., de Man, P., Wong, M., Muller, A. E., Renders, N. H., Bentvelsen, R. G., Buiting, A. G. M., Vlek, A. L. M., Stam, A. J., Troelstra, A., Overdevest, I. T. M. A., van Meer, M. P. A., dos Santos, C. O. & Wolfhagen, M. J. H. M., 1 Dec 2022, In: Annals of clinical microbiology and antimicrobials. 21, 1, 54.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusions

    van Osch, T. L. J., Pongracz, T., Geerdes, D. M., Mok, J. Y., van Esch, W. J. E., Voorberg, J., Kapur, R., Porcelijn, L., Kerkhoffs, J-L. H., van der Meer, P. F., van der Schoot, C. E., de Haas, M., Wuhrer, M. & Vidarsson, G., Dec 2022, In: Journal of thrombosis and haemostasis. 20, 12, p. 3011-3025 15 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP

    On behalf of the HOVON Lunenburg Lymphoma Phase I/II Consortium (LLPC), Dec 2022, In: Leukemia. 36, 12, p. 2853-2862 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

    Antic, D., Milic, N., Chatzikonstantinou, T., Scarfò, L., Otasevic, V., Rajovic, N., Allsup, D., Alonso Cabrero, A., Andres, M., Baile Gonzales, M., Capasso, A., Collado, R., Cordoba, R., Cuéllar-García, C., Correa, J. G., De Paoli, L., De Paolis, M. R., Del Poeta, G., Dimou, M., Doubek, M., & 81 othersEfstathopoulou, M., El-Ashwah, S., Enrico, A., Espinet, B., Farina, L., Ferrari, A., Foglietta, M., Lopez-Garcia, A., García-Marco, J. A., García-Serra, R., Gentile, M., Gimeno, E., da Silva, M. G., Gutwein, O., Hakobyan, Y. K., Herishanu, Y., Hernández-Rivas, J. Á., Herold, T., Itchaki, G., Jaksic, O., Janssens, A., Kalashnikova, O. B., Kalicińska, E., Kater, A. P., Kersting, S., Koren-Michowitz, M., Labrador, J., Lad, D., Laurenti, L., Fresa, A., Levin, M-D., Mayor Bastida, C., Malerba, L., Marasca, R., Marchetti, M., Marquet, J., Mihaljevic, B., Milosevic, I., Mirás, F., Morawska, M., Motta, M., Munir, T., Murru, R., Nunes, R., Olivieri, J., Pavlovsky, M. A., Piskunova, I., Popov, V. M., Quaglia, F. M., Quaresmini, G., Reda, G., Rigolin, G. M., Shrestha, A., Šimkovič, M., Smirnova, S., Špaček, M., Sportoletti, P., Stanca, O., Stavroyianni, N., Te Raa, D., Tomic, K., Tonino, S., Trentin, L., Van Der Spek, E., van Gelder, M., Varettoni, M., Visentin, A., Vitale, C., Vukovic, V., Wasik-Szczepanek, E., Wróbel, T., Segundo, L. Y. S., Yassin, M., Coscia, M., Rambaldi, A., Montserrat, E., Foà, R., Cuneo, A., Carrier, M., Ghia, P. & Stamatopoulos, K., Dec 2022, In: JOURNAL OF HEMATOLOGY & ONCOLOGY. 15, 1, p. 116 116.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

    Elsawy, M., Chavez, J. C., Avivi, I., Larouche, J-F., Wannesson, L., Cwynarski, K., Osman, K., Davison, K., Rudzki, J. D., Dahiya, S., Dorritie, K., Jaglowski, S., Radford, J., Morschhauser, F., Cunningham, D., Martin Garcia-Sancho, A., Tzachanis, D., Ulrickson, M. L., Karmali, R., Kekre, N., & 11 othersThieblemont, C., Enblad, G., Dreger, P., Malladi, R., Joshi, N., Wang, W-J., Solem, C. T., Snider, J. T., Cheng, P., To, C. & Kersten, M. J., 24 Nov 2022, In: Blood. 140, 21, p. 2248-2260 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma

    Leeksma, A. C., Derks, I. A. M., Garrick, B., Jongejan, A., Colombo, M., Bloedjes, T., Trowe, T., Leisten, J. C., Howarth, M., Malek, M., Mortensen, D. S., Blease, K., Groza, M. C., Narla, R. K., Loos, R., Kersten, M-J., Moerland, P. D., Guikema, J. E. J., Kater, A. P., Eldering, E., & 1 othersFilvaroff, E. H., 18 Nov 2022, (E-pub ahead of print) In: Molecular oncology.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Assessment of functional shunting in patients with sickle cell disease

    Afzali-Hashemi, L., Václavů, L., Wood, J. C., Biemond, B. J., Nederveen, A. J., Mutsaerts, H. J. M. M. & Schrantee, A., 1 Nov 2022, In: Haematologica. 107, 11, p. 2708-2719 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis

    Meeuwes, F. O., Brink, M., van der Poel, M. W. M., Kersten, M. J., Wondergem, M., Mutsaers, P. G. N. J., Böhmer, L., Woei-A-Jin, S., Visser, O., Oostvogels, R., Jansen, P. M., Diepstra, A., Snijders, T. J. F., Plattel, W. J., Huls, G. A., Vermaat, J. S. P. & Nijland, M., 1 Nov 2022, In: European Journal of Cancer. 176, p. 100-109 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study

    de Vos, T. W., Winkelhorst, D., Árnadóttir, V., van der Bom, J. G., Canals Surís, C., Caram-Deelder, C., Deschmann, E., Haysom, H. E., Hverven, H. B. C., Lozar Krivec, J., McQuilten, Z. K., Muñiz-Diaz, E., Nogués, N. R., Oepkes, D., Porcelijn, L., van der Schoot, C. E., Saxonhouse, M., Sola-Visner, M., Tiblad, E., Tiller, H., & 5 othersWood, E. M., Young, V., Železnik, M., de Haas, M. & Lopriore, E., 1 Nov 2022, In: The Lancet Haematology. 9, 11, p. e844-e853

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...130 Next

ID: 19903